1. 105001232 一种莫昔克丁的提纯方法
CN
28.10.2015
C07D 493/22 Loading...
C07D 493/22
Loading...
201510396558.0
安徽省皖北药业股份有限公司
丁振东
C07D 493/22
Loading...
本发明提供一种莫昔克丁的提纯方法，将莫昔克丁粗品与溶剂混合并加入抗氧剂，在60-80℃条件下搅拌制得溶液，然后加入溶析剂通过降温结晶，最后在真空条件下干燥获得纯度96%以上的高纯莫昔克丁；本发明具有结晶时间短、成本低、收率高的优点，为莫昔克丁纯度的提高提供了新方法。
2. 104860961 一种制备高纯度5-氧(对-硝基苯甲酰)-尼莫克汀的方法
CN
26.08.2015
C07D 493/22 Loading...
C07D 493/22
Loading...
201510168065.1
安徽省皖北药业股份有限公司
肖静静
C07D 493/22
Loading...
本发明公开一种制备高纯度5-氧（对-硝基苯甲酰）-尼莫克汀的方法，以尼莫克汀为反应起始原料，对硝基苯甲酰氯为-OH保护试剂制备5-氧（对-硝基苯甲酰）-尼莫克汀粗品，以5-氧（对-硝基苯甲酰）-尼莫克汀粗品为原料与溶剂混合，制得溶液，加入溶析剂，然后通过降温结晶，可以得到更高纯度的5-氧（对-硝基苯甲酰）-尼莫克汀；本发明具有结晶时间短、成本低、产品纯度和收率高等优点，为制备高纯度莫西克汀奠定了基础。
3. 104860960 一种制备高纯度5-氧(对-硝基苯甲酰)-23-氧代-LL-F28249的方法
CN
26.08.2015
C07D 493/22 Loading...
C07D 493/22
Loading...
201510168057.7
安徽省皖北药业股份有限公司
王珍
C07D 493/22
Loading...
本发明公开一种制备高纯度5-氧（对-硝基苯甲酰）-23-氧代-LL-F28249的方法，首先将5-氧（对-硝基苯甲酰）-23-氧代-LL-F28249粗品与溶剂混合制成溶液；然后加入溶析剂搅拌，控制温度进行结晶得到高纯度5-氧（对-硝基苯甲酰）-23-氧代-LL-F28249；本发明结晶周期短、成本低、收率高，操作简便，易实现工业化生产，为制备高纯度莫西菌素奠定了基础。
4. 203529175 一种滤渣定量螺旋下料装置
CN
09.04.2014
B65D 88/68 Loading...
B65D 88/68
Loading...
201320563344.4
安徽省皖北药业股份有限公司
王德强
B65D 88/68
Loading...
本实用新型公开了一种滤渣定量螺旋下料装置，包括料仓、安装在料仓顶部中心的传动装置、与传动装置输出轴相连的转动轴、安装在转动轴上部的桨叶、安装在转动轴下部的螺旋叶、安装在料仓底部的花盘，所述料仓的结构为上部圆柱体，中部圆锥体，下部圆柱体结合而成，其中上部圆柱体直径大于下部圆柱体直径，所述桨叶、螺旋叶位于料仓内。本实用新型采用立式螺旋下料，料仓中部的圆锥体结构很好的控制了下料的速度和均匀度，并能根据后续工序的处理能力改变出料速度，出料均匀，速度可控，完全满足现有生产的需要。
5. 203534252 一种蒸汽吸收装置
CN
09.04.2014
F28C 3/08 Loading...
F28C 3/08
Loading...
201320563360.3
安徽省皖北药业股份有限公司
王德强
F28C 3/08
Loading...
本实用新型公开了一种蒸汽吸收装置，包括吸收室、安装在吸收室上的平衡管、进汽管、排液管、雾化管，所述吸收室为中空的圆柱形与圆锥形结构组合而成，其中圆锥形结构的截面为等腰梯形，宽底与圆柱形连接，窄底与排液管连接；所述平衡管安装在吸收室的顶部中间，所述进汽管和雾化管安装在吸收室圆柱形结构的不同侧面。本实用新型通过进汽管将废汽引入吸收室，不但能解决废汽排放带来的环保问题，同时利用废蒸汽将清水加热至一定温度，供污水生化处理中的配热或其它的热水加热使用，减少能源浪费的同时带来一定的经济效益。
6. 103103240 一种提高那西肽产量的菌种培养方法
CN
15.05.2013
C12P 21/02 Loading...
C12P 21/02
Loading...
201310027757.5
安徽省皖北药业股份有限公司
秦艳飞
C12P 21/02
Loading...
本发明公开一种提高那西肽产量的菌种培养方法，包括那西肽产生菌的斜面培养基，其特征在于，所述那西肽产生菌的斜面培养基经过消毒后按100～1000微克/毫升的量加入半胱氨酸，然后接种那西肽产生菌的沙土孢子进行菌种培养，孢子培养成熟后接种到摇瓶中进行发酵；本发明通过在斜面培养基添加适量的半胱氨酸，改善那西肽产生菌的孢子质量，可明显提高那西肽的产量。
7. 103060292 一种提高右旋糖酐酶酶活单位的发酵方法
CN
24.04.2013
C12N 9/46 Loading...
C12N 9/46
Loading...
201310000980.0
安徽省皖北药业股份有限公司
曹新年
C12N 9/46
Loading...
本发明公开一种提高右旋糖酐酶酶活单位的发酵方法，发酵过程中，当发酵培养基的总糖量降至0.26%时，向发酵培养基中连续流加右旋糖酐液，其中右旋糖酐的含量为发酵培养基总重量的0.5-1.5%，继续发酵，当发酵培养基的总糖量降至0.20%时，向发酵培养基中连续流加右旋糖酐液，其中右旋糖酐的含量为发酵培养基总重量的0.5-1.5%，继续发酵160-170小时后结束发酵；本发明通过在右旋糖酐酶发酵过程中后期补入适量的右旋糖酐作为生产右旋糖酐酶的持续性诱剂，其产酶时间延长，酶活单位增幅明显，最大增幅达18%，本发明具有操作性强，投入低、产出高的优点。
8. 202246688 一种发酵罐接种装置
CN
30.05.2012
C12M 1/26 Loading...
C12M 1/26
Loading...
201120128532.5
安徽省皖北药业股份有限公司
朱振坤
C12M 1/26
Loading...
本实用新型公开了一种发酵罐接种装置，包括种子罐（8）、发酵罐（9）和分别连接于种子罐（8）和发酵罐（9）底部的第一轴塞阀（4）和第二轴塞阀（2），第一轴塞阀（4）的下方与旁通阀（6）、第一下方阀（5）连通，第二轴塞阀（2）的下方与第一蒸汽阀（1）、第二下方阀（3）连通，且旁通阀（6）和第一下方阀（1）相互连通，第一蒸汽阀（1）和第二下方阀（3）相互连通，第一下方阀（5）和第二下方阀（3）之间活动连接有波纹软管（10）。本实用新型结构简单，操作方便，保证了接种量的的准确，且防止了剩余接种液导致再次接种发酵失败的问题。
9. 202146635 一种压缩空气除湿装置
CN
22.02.2012
B01D 5/00 Loading...
B01D 5/00
Loading...
201120128535.9
安徽省皖北药业股份有限公司
朱振坤
B01D 5/00
Loading...
本实用新型公开了一种压缩空气除湿装置，包括带有夹套（2）的储罐（1），储罐（1）的下部沿储罐圆周切线方向设置有切线进气口（3），其上部设置有出气口（4），夹套（2）的上部设置有出水口（5），下部设置有进水口（6）。本实用新型结构简单、成本低、使用和操作方便，满足压缩空气除湿、冷却的目的。
10. 102070499 Refining method of tiamulin hydrogen fumarate
CN
25.05.2011
C07C 323/52 Loading...
C07C 323/52
Loading...
201010567400.2
Anhui Wanbei Pharmaceutical Co., Ltd.
Hui Jian
C07C 323/52
Loading...
The invention relates to a refining method of tiamulin hydrogen fumarate. The method is characterized by comprising the following steps: taking crude tiamulin hydrogen fumarate, adding crude tiamulin hydrogen fumarate in acetone in a weight ratio of 1:3-4; stirring at 35-45rpm while heating to 55-57 DEG C, refluxing for 3-5h while keeping the temperature; reducing the temperature at 8-10 DEG C/h, reducing the stirring speed to 18-22rpm, refluxing for crystallization; adding a defined amount of tiamulin hydrogen fumarate seed crystals when the temperature is reduced to 48 DEG C, keeping the temperature for 2-3h when the temperature is reduced to 1 DEG C to perform complete crystallization; performing suction filtering with a suction filtering machine to ensure that no filtrate drops, adding a defined amount of cold acetone to wash twice, removing impurities to draw off water and generate the refined tiamulin hydrogen fumarate powder; and placing the refined powder in a vacuum drying oven, heating at 6 DEG C/h to 55-65 DEG C, and drying for 2-4h under the vacuum degree of -(0.07-0.09)MPa to obtain the refined tiamulin hydrogen fumarate raw powder. The invention utilizes the property of tiamulin hydrogen fumarate that tiamulin hydrogen fumarate is slightly soluble in acetone, thus the dosage of the refined solvent can be reduced, the consumption of solvent can be lowered, the production cost can be reduced, the impurities of the product can be reduced and the product quality can be greatly increased.
11. 102018960 Method for keeping quality stability of clindamycin phosphate injection
CN
20.04.2011
A61K 47/02 Loading...
A61K 47/02
Loading...
201010567417.8
Anhui Wanbei Pharmaceutical Co., Ltd.
Wang Xing
A61K 47/02
Loading...
The invention relates to a method for keeping quality stability of clindamycin phosphate injection. The method is characterized by comprising the following steps of: (1) adding an antioxidant in an amount which accounts for 0.05 to 4 percent of the total mass of the clindamycin phosphate injection into the prepared clindamycin phosphate injection and fully stirring to dissolve the antioxidant; and (2) introducing nitrogen gas into the solution at the flow velocity of 2ml/minute for 10 to 20 minutes and sealing the injection, wherein the antioxidant is sodium sulfite. Because a certain amount of antioxidant is added into the clindamycin phosphate injection, clindamycin phosphate can be protected from being oxidized; and because the nitrogen gas is introduced into the clindamycin phosphate injection to replace oxygen in the solution, the clindamycin phosphate is protected from being oxidized; therefore, the clindamycin phosphate has stable quality in the solution and is difficult to degrade and oxidize; and the medication safety of the clindamycin phosphate is improved. The method is easy to operate, has low cost and contributes to wide popularization.
12. 101948826 Method for screening methionine resistant deinsectization streptomyces avermitilis strain
CN
19.01.2011
C12N 13/00 Loading...
C12N 13/00
Loading...
201010266054.4
Anhui Wanbei Pharmaceutical Co., Ltd.
Yang Chunli
C12N 13/00
Loading...
The invention discloses a method for screening a methionine resistant deinsectization streptomyces avermitilis strain, which belongs to the field of the screening of microbial strains. The method comprises the following steps of: performing ultraviolet mutagenesis on deinsectization streptomyces avermitilis spore suspension; performing enrichment on tolerant strains by using a methionine-containing liquid culture medium; screening methionine solid-plate tolerant strains; and screening strains of which the shake flask capacity is improved compared with that of parent strains through preliminary screening, secondary screening and genetic stability research so as to provide a feasible method for screening the deinsectization streptomyces avermitilis strain. The shake flask production capacity of the deinsectization streptomyces avermitilis strain screened by the method is greatly improved, and the genetic stability is high.
13. 101928307 Crystallization method of clindamycin phosphate
CN
29.12.2010
C07H 15/16 Loading...
C07H 15/16
Loading...
201010266045.5
Anhui Wanbei Pharmaceutical Co., Ltd.
Xia Shouyou
C07H 15/16
Loading...
The invention discloses a crystallization method of clindamycin phosphate, comprising the following steps: firstly dissolving the clindamycin phosphate in n-butanol aqueous solution; then performing crystallization after decoloration, concentration and stepped temperature reduction to below 25 DEG C, filtering, washing, and drying to obtain the finished product. The crystallization method of the clindamycin phosphate of the invention has high crystallization yield, saves the time and reduces the cost; and the clindamycin phosphate finished product has high purity, good mobility and less possibility of agglomeration.
14. 201581077 一种改进的微生物斜面接种铲
CN
15.09.2010
C12M 1/26 Loading...
C12M 1/26
Loading...
200920180859.X
安徽省皖北药业股份有限公司
杨春丽
C12M 1/26
Loading...
本实用新型涉及一种改进的微生物斜面接种铲，包括铲柄(1)和铲面(2)，其特征在于：铲柄铲面为一体，铲面一侧设有倾斜面(3)。本实用新型的有益效果是结构简单，方便实用，工艺合理，适用于斜面接种操作。
15. 201581069 发酵罐密封装置
CN
15.09.2010
C12M 1/00 Loading...
C12M 1/00
Loading...
200920180858.5
安徽省皖北药业股份有限公司
刘玉祥
C12M 1/00
Loading...
本实用新型涉及发酵罐密封装置，包括弹簧座(1)，弹簧座(1)通过弹簧(2)、螺栓与动环(3)连接，弹簧座与动环间还设有O型密封圈(5)，动环下设有静环(6)，静环(6)通过静环压盖(4)固定在底盘(8)上，在静环(6)和底盘(8)间还设有石棉密封圈(7)，底盘设在罐体上封头(9)上，其特征在于：底盘(8)中部为罐口法兰，罐口法兰上设有静环底座，罐口法兰下与罐体上封头(9)相配合；底盘边缘与罐体上封头焊接连接。本实用新型的有益效果是完全避免了因传统机械密封结构的不合理性引起的染菌问题，整体结构简单，便于加工及装配。
16. 201581075 微生物发酵实验罐补料装置
CN
15.09.2010
C12M 1/12 Loading...
C12M 1/12
Loading...
200920180857.0
安徽省皖北药业股份有限公司
朱振坤
C12M 1/12
Loading...
本实用新型涉及微生物发酵实验罐补料装置，包括发酵试验罐(10)，其特征在于：另外还设有物料消毒罐(3)，物料消毒罐一侧设有进料管(2)，另一侧设有补料管(4)，补料管端口与胶管(6)一端连接，胶管(6)上设有补料泵(7)，胶管另一端与隔膜阀(8)一端连接，隔膜阀另一端与发酵试验罐(10)的进料管连接。本实用新型的有益效果是避免了实验室发酵实验因频繁更换物料造成的中间染菌问题；可以实现补料的随时安全切换、物料制备的彻底灭菌；保证消毒质量和过程管路彻底灭菌，大大提高实验效率。
17. 201505580 一种高效旋风分离器
CN
16.06.2010
B04C 5/08 Loading...
B04C 5/08
Loading...
200920186781.2
安徽省皖北药业股份有限公司
刘玉祥
B04C 5/08
Loading...
本实用新型属于发酵领域的排气系统，特别是涉及一种旋风分离器，包括由圆柱体和圆锥体组成的壳体(4)，壳体上部设有引入管(3)、引出管(1)、导流管(2)，下部设有下降管(5)，其特征是：导流管(2)的旋转长度及的旋转角均为360°；导流管(2)的内边螺旋升角α2＝15°-16°，导流管(2)的外边螺旋升角α1＝9°-10°，α2/α1＝1.5-1.67。本实用新型通过结构的改进并应用于气液分离，可收到理想的有益效果，分离效率可达90％以上。
18. 101624411 Method and device for preparing lincomycin hydrochloride
CN
13.01.2010
C07H 15/16 Loading...
C07H 15/16
Loading...
200910144359.5
Anhui Wanbei Pharmaceutical Co., Ltd.
Huang Wei
C07H 15/16
Loading...
The invention relates to a method and a device for preparing lincomycin hydrochloride. On the basis of the prior lincomycin hydrochloride production, repurifying processing procedure is added to prepare lincomycin hydrochloride with lincomycin B component less than or equal to 0.1 percent. The method is characterized by comprising the following steps: lincomycin hydrochloride with B component less than or equal to 1.0 percent is dissolved to have thetconcentration of 80000-100000 microgramme/ml, the pH value is adjusted to 10-11, extraction is carried out in extraction tower with 1/2-1/3 (weight ratio) of 2-octanol, the extraction temperature is 20-30 DEG C, the pH value of extraction liquid is adjusted to 2-4 by hydrochloric acid for back extraction, and acetone is used for crystallization. By adopting the method and the extraction tower device, the concentration of B component in lincomycin hydrochloride can be effectively reduced to be less than or equal to 0.1 percent, so that the quality of lincomycin hydrochloride is improved, and the yield is increased by 5-7 percent.
19. 101624418 Method for preparing nosiheptide powder
CN
13.01.2010
C07K 7/56 Loading...
C07K 7/56
Loading...
200910144358.0
Anhui Wanbei Pharmaceutical Co., Ltd.
Li Weiquan
C07K 7/56
Loading...
The invention discloses a method for preparing nosiheptide powder, which comprises the following steps: a. carrying out metallic membrane filtration on fermentation liquid containing nosiheptide obtained in fermentation by using a metal pipe type membrane separator and carrying out concentration treatment to remove 20-35 percent of water in the fermentation liquid to obtain concentrated liquid; b. carrying out spray drying treatment on the obtained concentrated liquid to obtain powder containing nosiheptide; adding auxiliary materials into the nosiheptide powder and diluting the nisiheptide powder level by level to prepare nosiheptide preparations with different forms. The invention has the advantages that nosiheptide can be completely extracted from the fermented liquid of nosiheptide, and the method has high yield, low cost and no environmental pollution.
20. 101525653 Detection method of nosiheptide preparation
CN
09.09.2009
C12Q 1/18 Loading...
C12Q 1/18
Loading...
200910116489.8
Anhui Wanbei Pharmaceutical Co., Ltd.
Liu Ruihua
C12Q 1/18
Loading...
The invention relates to a detection method of a nosiheptide preparation. The detection method is characterized in that: first, the nosiheptide preparation is pre-treated according to the following steps: (1) borax mixed solution is prepared: borax solution 0.01M:water:absolute ethyl alcohol=1:1:2; (2) the nosiheptide preparation and the borax mixed solution are mixed to obtain leaching solution and concentration of the nosiheptide preparation in the leaching solution is controlled at 240-260mu/ml; and (3) the leaching solution is ultrasonically processed for 15min and then mixing at 37 DEG C for 2h, the obtained supernatant is cultivated, determined and calculated according to 'Microbial Detection Method of Antibiotics' on page 103 of Appendix of Chinese Veterinary Pharmacopoeia 2005. The detection method has the advantages of being capable of ensuring the best pH value when the ethyl alcohol is extracted and being capable of completely extracting nosiheptide by adopting ultrasonic pretreatment and using the borax mixed solution with weak buffer capacity, thus ensuring accuracy and reliability of assay results of different nosiheptide preparation products.
21. 101519434 Extraction process of nosiheptide raw powder
CN
02.09.2009
C07K 7/08 Loading...
C07K 7/08
Loading...
200910116488.3
Anhui Wanbei Pharmaceutical Co., Ltd.
Liu Ruihua
C07K 7/08
Loading...
The invention discloses an extraction process of nosiheptide raw powder. The original method using a centrifuge to separate zymotic fluid is changed to use a sheet frame to filter, thus the handling capacity in unit time is greatly improved and the equipment investment is reduced; in a crude product crystallization step, a definite mass of water is added in nosiheptide when concentration is finished by utilizing the characteristic that the nosiheptide is not dissolved in water, therefore, not only the cost is not increased, but also the yield coefficient ( the current yield coefficient is about 60 percent, and the yield coefficient of the invention is over 75 percent) can be greatly improved; in a refining step, the original butanol extraction is changed into water rinse so as to achieve the purpose of purification; and the valence of the nosiheptide raw powder produced by an improved refining process can reach 920-980 microgrammes/microgram, therefore, not only the product content is greatly improved, but also the production cost is greatly lowered by changing solvent extraction into acid water rinse. The extraction process has the advantages of simple process, high yield coefficient, good quality, and the like, thereby having commercial production conditions.

